A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis

BJU International

Volumn 85, Issue 4, 2000, Pages 421-426

  Cartledge, J J ^a   Davies, A M ^a   Eardley, I ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Interstitial cystitis; L arginine; Nitric oxide; Symptoms; Treatment

Indexed keywords

ARGININE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FLUSHING; HEADACHE; HUMAN; INTERSTITIAL CYSTITIS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SWEATING;

ADULT; AGED; ARGININE; CROSS-OVER STUDIES; CYSTITIS, INTERSTITIAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0034005551     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00490.x     Document Type: Article

References (23)

1. 1 Oravista KJ. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenniae 1975; 45: 587-90
2. 2 Bade JJ, Rijcken B, Mensink HJ. Interstitial cystitis in The Netherlands: prevalence, diagnostic criteria and therapeutic preferences. J Urol 1995; 154: 2035-7
3. 3 Held PJ, Hanno PM, Wein AJ et al. Epidemiology of interstitial cystitis: 2. In Hanno PM, Staskin DR, Krane RJ, Wein AJ, eds. Interstitial Cystitis. London, Springer-Verlag, 1990: 29-48
4. 4 Jones CA, Harris M, Nyberg L. Prevalence of interstitial cystitis in the United States. J Urol 1994; 151: 423A
5. 5 Hanno P. Interstitial cystitis and related diseases. In Walsh PC, Retik AB, Darracott Vaughan E, Wein AJ, eds. Campbell's Urology. Philadelphia: WB Saunders, 1998: 632
6. 6 Smith SD, Wheeler MA, Foster He Jr, Weiss RM. Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections. J Urol 1996; 155: 1432-5
7. 7 Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesise nitric oxide from L-arginine. Nature 1988; 333: 664-6
8. 8 Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6
9. 9 Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994; 266: G222,
10. 10 De Groat WC, Erdman SL, Vizzard MA. Increased expression of neuronal nitric oxide synthase (NOS), FOS and growth associated proteins (GAP-43) in neuronal pathways following acute and chronic irritation of the urinary tract or following peripheral nerve injury in rats. Interstitial Cystitis Symposium, National Institutes of Health, Bethesda MD, January 9-11 1995: 89
11. 11 Brzozowski T, Konturek SJ, Drozdowicz D, Dembinski A, Stachura J. Healing of chronic gastric ulcerations by L-arginine. Role of nitric oxide, prostaglandins, gastrin and polyamines. Digestion 1995; 56: 463
12. 12 Sukumar P, Loo A, Magur E, Nandi J, Oler A, Levine RA. Dietary supplementation of nucleotides and arginine promotes healing of small bowel ulcers in experimental ulcerative ileitis. Digestive Dis Sci 1997; 42: 1530-6
13. 13 Tenenbaum A, Fisman EZ, Motro M. L-Arginine: rediscovery in progress. Cardiology 1998; 90: 153-9
14. 14 Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H. Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomised, placebo-controlled study. BJU Int 1999; 83: 269-73
15. 15 Smith SD, Wheeler MA, Foster He Jr, Weiss RM. Efficacy of oral L-arginine treatment for interstitial cystitis: The role of nitric oxide synthase. J Urol 1996; 155: 439A
16. 16 Smith SD, Wheeler MA, Foster He Jr, Weiss RM. Improvement in interstitial cystitis symptom scores during treatment with oral L-arginine. J Urol 1997; 158: 703-8
17. 17 Korting GE, Smith SD, Wheeler MA, Weiss RM, Foster He Jr A randomised double-blind trial of oral L-arginine for treatment of interstitial cystitis. J Urol 1999; 161: 558-65,
18. 18 Ehren I, Lundberg JO, Adolfsson J, Wiklund NP. Effects of L-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis. Urology 1998; 52: 1026-9
19. 19 Calver A, Collier J, Vallance P. L-arginine induced hypotension. Lancet 1990; 336: 1016-7
20. 20 O'Leary MP, Sant GR, Fowler FJ, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997; 49: 58-63
21. 21 Boyd JR, Olin BR, eds. Facts and Comparisons, Facts and Comparisons Division. St Louis: JP Lippincott Co., 1984
22. 22 Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L. The diagnosis of interstitial cystitis revisited: Lessons learned from the National Institutes of Health Interstitial Cystitis database study. J Urol 1999; 161: 553-7
23. 23 Wheeler MA, Smith SD, Saito N, Foster HE Jr, Weiss RM. Effect of long-term oral L-arginine on the nitric oxide synthase pathway in the urine from patients with interstitial cystitis. J Urol 1997; 158: 24